|
1
|
Miller CR and Perry A: Glioblastoma. Arch
Pathol Lab Med. 131:397–406. 2007.
|
|
2
|
Komori T, Sasaki H and Yoshida K: Revised
WHO classification of tumours of the central nervous system:
Summary of the revision and perspective. No Shinkei Geka.
44:625–635. 2016.(In Japanese).
|
|
3
|
Easaw JC, Mason WP, Perry J, Laperrière N,
Eisenstat DD, Del Maestro R, Bélanger K, Fulton D and Macdonald D:
Canadian Glioblastoma Recommendations Committee: Canadian
recommendations for the treatment of recurrent or progressive
glioblastoma multiforme. Curr Oncol. 18:e126–e136. 2011. View Article : Google Scholar :
|
|
4
|
Smith AW, Mehta MP and Wernicke AG: Neural
stem cells, the subventricular zone and radiotherapy: Implications
for treating glioblastoma. J Neurooncol. 128:207–216. 2016.
View Article : Google Scholar
|
|
5
|
Binder DC, Davis AA and Wainwright DA:
Immunotherapy for cancer in the central nervous system: Current and
future directions. Oncoimmunology. 5:e10820272016. View Article : Google Scholar
|
|
6
|
Katakowski M and Chopp M: Exosomes as
tools to suppress primary brain tumor. Cell Mol Neurobiol.
36:343–352. 2016. View Article : Google Scholar
|
|
7
|
Khosla D: Concurrent therapy to enhance
radiotherapeutic outcomes in glioblastoma. Ann Transl Med.
4:542016.
|
|
8
|
Kegelman TP, Hu B, Emdad L, Das SK, Sarkar
D and Fisher PB: In vivo modeling of malignant glioma: The road to
effective therapy. Adv Cancer Res. 121:261–330. 2014. View Article : Google Scholar
|
|
9
|
Van Meir EG, Hadjipanayis CG, Norden AD,
Shu HK, Wen PY and Olson JJ: Exciting new advances in
neuro-oncology: The avenue to a cure for malignant glioma. CA
Cancer J Clin. 60:166–193. 2010. View Article : Google Scholar :
|
|
10
|
Alvarez-Garcia I and Miska EA: MicroRNA
functions in animal development and human disease. Development.
132:4653–4662. 2005. View Article : Google Scholar
|
|
11
|
He L and Hannon GJ: MicroRNAs: Small RNAs
with a big role in gene regulation. Nat Rev Genet. 5:522–531. 2004.
View Article : Google Scholar
|
|
12
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar
|
|
13
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar
|
|
14
|
Wang Z, Yang J, Xu G, Wang W, Liu C, Yang
H, Yu Z, Lei Q, Xiao L, Xiong J, et al: Targeting miR-381-NEFL axis
sensitizes glioblastoma cells to temozolomide by regulating
stemness factors and multidrug resistance factors. Oncotarget.
6:3147–3164. 2015. View Article : Google Scholar
|
|
15
|
Chang JH, Hwang YH, Lee DJ, Kim DH, Park
JM, Wu HG and Kim IA: MicroRNA-203 modulates the radiation
sensitivity of human malignant glioma cells. Int J Radiat Oncol
Biol Phys. 94:412–420. 2016. View Article : Google Scholar
|
|
16
|
Sampson VB, Yoo S, Kumar A, Vetter NS and
Kolb EA: MicroRNAs and potential targets in osteosarcoma: Review.
Front Pediatr. 3:692015. View Article : Google Scholar :
|
|
17
|
Luna-Aguirre CM, de la Luz Martinez-Fierro
M, Mar-Aguilar F, Garza-Veloz I, Treviño-Alvarado V, Rojas-Martinez
A, Jaime-Perez JC, Malagon-Santiago GI, Gutierrez-Aguirre CH,
Gonzalez-Llano O, et al: Circulating microRNA expression profile in
B-cell acute lymphoblastic leukemia. Cancer Biomark. 15:299–310.
2015. View Article : Google Scholar
|
|
18
|
Kagiya T: MicroRNAs and osteolytic bone
metastasis: The roles of MicroRNAs in tumor-induced osteoclast
differentiation. J Clin Med. 4:1741–1752. 2015. View Article : Google Scholar :
|
|
19
|
Ventura A and Jacks T: MicroRNAs and
cancer: Short RNAs go a long way. Cell. 136:586–591. 2009.
View Article : Google Scholar :
|
|
20
|
Gao B, Gao K, Li L, Huang Z and Lin L:
miR-184 functions as an oncogenic regulator in hepatocellular
carcinoma (HCC). Biomed Pharmacother. 68:143–148. 2014. View Article : Google Scholar
|
|
21
|
Yang L, Wei QM, Zhang XW, Sheng Q and Yan
XT: MiR-376a promotion of proliferation and metastases in ovarian
cancer: Potential role as a biomarker. Life Sci. 173:62–67. 2017.
View Article : Google Scholar
|
|
22
|
Zheng Y, Yin L, Chen H, Yang S, Pan C, Lu
S, Miao M and Jiao B: miR-376a suppresses proliferation and induces
apoptosis in hepatocellular carcinoma. FEBS Lett. 586:2396–2403.
2012. View Article : Google Scholar
|
|
23
|
Zheng Y, Chen H, Yin M, Ye X, Chen G, Zhou
X, Yin L, Zhang C and Ding B: MiR-376a and histone deacetylation 9
form a regulatory circuitry in hepatocellular carcinoma. Cell
Physiol Biochem. 35:729–739. 2015. View Article : Google Scholar
|
|
24
|
Guan H, Cai J, Zhang N, Wu J, Yuan J, Li J
and Li M: Sp1 is upregulated in human glioma, promotes
MMP-2-mediated cell invasion and predicts poor clinical outcome.
Int J Cancer. 130:593–601. 2012. View Article : Google Scholar
|
|
25
|
Luo J, Wang X, Xia Z, Yang L, Ding Z, Chen
S, Lai B and Zhang N: Transcriptional factor specificity protein 1
(SP1) promotes the proliferation of glioma cells by up-regulating
midkine (MDK). Mol Biol Cell. 26:430–439. 2015. View Article : Google Scholar :
|
|
26
|
Dong Q, Cai N, Tao T, Zhang R, Yan W, Li
R, Zhang J, Luo H, Shi Y, Luan W, et al: An axis involving SNAI1,
microRNA-128 and SP1 modulates glioma progression. PLoS One.
9:e986512014. View Article : Google Scholar :
|
|
27
|
Lee WS, Kwon J, Yun DH, Lee YN, Woo EY,
Park MJ, Lee JS, Han YH and Bae IH: Specificity protein 1
expression contributes to Bcl-w-induced aggressiveness in
glioblastoma multiforme. Mol Cells. 37:17–23. 2014. View Article : Google Scholar :
|
|
28
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
|
29
|
Zhou X, Ren Y, Moore L, Mei M, You Y, Xu
P, Wang B, Wang G, Jia Z, Pu P, et al: Downregulation of miR-21
inhibits EGFR pathway and suppresses the growth of human
glioblastoma cells independent of PTEN status. Lab Invest.
90:144–155. 2010. View Article : Google Scholar
|
|
30
|
Ma R, Yan W, Zhang G, Lv H, Liu Z, Fang F,
Zhang W, Zhang J, Tao T, You Y, et al: Upregulation of miR-196b
confers a poor prognosis in glioblastoma patients via inducing a
proliferative phenotype. PLoS One. 7:e380962012. View Article : Google Scholar :
|
|
31
|
Qu S, Yao Y, Shang C, Xue Y, Ma J, Li Z
and Liu Y: MicroRNA-330 is an oncogenic factor in glioblastoma
cells by regulating SH3GL2 gene. PLoS One. 7:e460102012. View Article : Google Scholar :
|
|
32
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar
|
|
33
|
Meng X, Joosse SA, Müler V, Trillsch F,
Milde-Langosch K, Mahner S, Geffken M, Pantel K and Schwarzenbach
H: Diagnostic and prognostic potential of serum miR-7, miR-16,
miR-25, miR-93, miR-182, miR-376a and miR-429 in ovarian cancer
patients. Br J Cancer. 113:1358–1366. 2015. View Article : Google Scholar :
|
|
34
|
Formosa A, Markert EK, Lena AM, Italiano
D, Finazzi-Agro' E, Levine AJ, Bernardini S, Garabadgiu AV, Melino
G and Candi E: MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c,
miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p,
mapped to the 14q32.31 locus, regulate proliferation, apoptosis,
migration and invasion in metastatic prostate cancer cells.
Oncogene. 33:5173–5182. 2014. View Article : Google Scholar
|
|
35
|
Fellenberg J, Sähr H, Kunz P, Zhao Z, Liu
L, Tichy D and Herr I: Restoration of miR-127-3p and miR-376a-3p
counteracts the neoplastic phenotype of giant cell tumor of bone
derived stromal cells by targeting COA1, GLE1 and PDIA6. Cancer
Lett. 371:134–141. 2016. View Article : Google Scholar
|
|
36
|
Yu Z, Ni L, Chen D, Zhang Q, Su Z, Wang Y,
Yu W, Wu X, Ye J, Yang S, et al: Identification of miR-7 as an
oncogene in renal cell carcinoma. J Mol Histol. 44:669–677. 2013.
View Article : Google Scholar
|
|
37
|
Zehavi L, Avraham R, Barzilai A, Bar-Ilan
D, Navon R, Sidi Y, Avni D and Leibowitz-Amit R: Silencing of a
large microRNA cluster on human chromosome 14q32 in melanoma:
Biological effects of mir-376a and mir-376c on insulin growth
factor 1 receptor. Mol Cancer. 11:442012. View Article : Google Scholar :
|
|
38
|
Kanai M, Wei D, Li Q, Jia Z, Ajani J, Le
X, Yao J and Xie K: Loss of Krüppel-like factor 4 expression
contributes to Sp1 overexpression and human gastric cancer
development and progression. Clin Cancer Res. 12:6395–6402. 2006.
View Article : Google Scholar
|
|
39
|
Hosoi Y, Watanabe T, Nakagawa K, Matsumoto
Y, Enomoto A, Morita A, Nagawa H and Suzuki N: Up-regulation of
DNA-dependent protein kinase activity and Sp1 in colorectal cancer.
Int J Oncol. 25:461–468. 2004.
|
|
40
|
Yin P, Zhao C, Li Z, Mei C, Yao W, Liu Y,
Li N, Qi J, Wang L, Shi Y, et al: Sp1 is involved in regulation of
cystathionine γ-lyase gene expression and biological function by
PI3K/Akt pathway in human hepatocellular carcinoma cell lines. Cell
Signal. 24:1229–1240. 2012. View Article : Google Scholar
|
|
41
|
Sankpal UT, Goodison S, Abdelrahim M and
Basha R: Targeting Sp1 transcription factors in prostate cancer
therapy. Med Chem. 7:518–525. 2011. View Article : Google Scholar
|
|
42
|
Chiefari E, Brunetti A, Arturi F, Bidart
JM, Russo D, Schlumberger M and Filetti S: Increased expression of
AP2 and Sp1 transcription factors in human thyroid tumors: A role
in NIS expression regulation? BMC Cancer. 2:352002. View Article : Google Scholar :
|
|
43
|
Beishline K and Azizkhan-Clifford J: Sp1
and the ‘hallmarks of cancer’. FEBS J. 282:224–258. 2015.
View Article : Google Scholar
|
|
44
|
Wang YT, Yang WB, Chang WC and Hung JJ:
Interplay of posttranslational modifications in Sp1 mediates Sp1
stability during cell cycle progression. J Mol Biol. 414:1–14.
2011. View Article : Google Scholar
|
|
45
|
Yen WH, Ke WS, Hung JJ, Chen TM, Chen JS
and Sun HS: Sp1-mediated ectopic expression of T-cell lymphoma
invasion and metastasis 2 in hepatocellular carcinoma. Cancer Med.
5:465–477. 2016. View
Article : Google Scholar :
|
